首页> 美国卫生研究院文献>other >Characterization of the mixed axial ligand complex (4-cyanopyridine)(imidazole)(tetramesitylporphinato)iron(iii) perchlorate. Stabilization by synergic bonding
【2h】

Characterization of the mixed axial ligand complex (4-cyanopyridine)(imidazole)(tetramesitylporphinato)iron(iii) perchlorate. Stabilization by synergic bonding

机译:混合轴向配位体配合物(4-氰基吡啶)(咪唑)(四甲基卟啉)高氯酸铁(iii)的表征。通过协同键稳定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The reaction of [Fe(TMP)(OClO3)], where TMP is the dianion of tetramesitylporphyrin, with a combination of a strong π-acceptor ligand and a π-donating imidazole can lead to the preparation of mixed-ligand complexes [Fe(Porph)(4-CNPy)(L)]+ where L is imidazole itself or 1-acetylimidazole and 4-cyanopyridine is the strong π acceptor ligand. The stability of the new mixed-ligand pair is the presumed result of synergic bonding between the two axial ligands. The molecular structure and other characterization of the new mixed axial ligand complex, [Fe(TMP)(4-CNPy)(HIm)]ClO4 is described. The axial ligands have a relative perpendicular arrangement with Fe–N(imidazole) = 1.945 Å and Fe–N(pyridine) = 2.021 Å The average equatorial Fe–Np distance is 1.963 Å, which is consistent with the S4-ruffled TMP core. Despite the relative perpendicular arrangement of axial ligands, the EPR spectrum of the complex is a rhombic signal and not a large gmax signal. The EPR g-values are g1 = 3.05, g2 = 2.07, and g3 = 1.22. A quadrupole doublet was seen in the Mössbauer spectrum with an isomer shift of 0.197 mm/s and quadrupole splitting of 1.935 mm/s. Two crystalline forms of [Fe(TMP)(4-CNPy)(HIm)]ClO4 have been characterized; the two forms differ only in the solvent content of the lattice. Crystal data for form >A: a = 15.432 (12) Å, b = 20.696 (2) Å, c = 19.970 (5) Å, and β = 99.256 (14)°, monoclinic, space group P21, V = 6295 (2) Å3, Z = 4, formula FeCl3O4N8C69H69, 8397 observed data, R1 = 0.086, wR2 = 0.210, refinement on F 2. Crystal data for form >B: a = 15.267 (3) Å, b = 20.377 (6) Å, c = 19.670 (4) Å, and β = 98.14 (1)°, monoclinic, space group P21, V = 6058 (4) Å3, Z = 4, formula C65.25H60.5Cl1.5FeN8O4, 5464 observed data, R1 = 0.096, wR2 = 0.112, refinement on F.
机译:[Fe(TMP)(OClO3)](其中TMP是四甲基卟啉的二价阴离子)与强π-受体配体和π-供体咪唑的组合反应可导致制备混合配体复合物[Fe( Porph)(4-CNPy)(L)] + 其中L是咪唑本身或1-乙酰基咪唑,而4-cyanopyridine是强π受体配体。新的混合配体对的稳定性是两个轴向配体之间协同结合的推测结果。描述了新的混合轴向配体配合物[Fe(TMP)(4-CNPy)(HIm)] ClO4的分子结构和其他表征。轴向配体具有相对垂直的排列,其中Fe–N(咪唑)= 1.945Å,Fe–N(吡啶)= 2.021Å。平均赤道Fe–Np距离为1.963Å,与S4褶皱的TMP核芯一致。尽管轴向配体相对垂直排列,但配合物的EPR谱是菱形信号,而不是大gmax信号。 EPR g值为g1 = 3.05,g2 = 2.07和g3 = 1.22。在Mössbauer光谱中看到四极双峰,异构体位移为0.197 mm / s,四极分裂为1.935 mm / s。 [Fe(TMP)(4-CNPy)(HIm)] ClO4的两种结晶形式已得到表征;这两种形式仅在晶格中的溶剂含量上不同。 > A 形式的晶体数据:a = 15.432(12)Å,b = 20.696(2)Å,c = 19.970(5)Å,β= 99.256(14)°,单斜面,空间群P21 / n,V = 6295(2)Å 3 ,Z = 4,公式FeCl3O4N8C69H69,8397实测数据,R1 = 0.086,wR 2 = 0.210,对F进行细化 2 。 > B 形式的晶体数据:a = 15.267(3)Å,b = 20.377(6)Å,c = 19.670(4)Å,β= 98.14(1)°,单斜面,空间群P2 1 / n,V = 6058(4)Å 3 ,Z = 4,公式C 65.25 H 60.5 Cl 1.5 FeN 8 O 4 ,观察到数据5464,R 1 = 0.096,wR 2 = 0.112,在 F 上进行细化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号